Alzheimer's blood biomarker tracks brain amyloid similarly across racial groups, study finds

Дата публикации: 13-10-2026 18:20:08

A large global study provides new evidence supporting the use of blood biomarkers in an Alzheimer's clinical trial to screen for elevated brain amyloid levels among potential participants who are cognitively unimpaired. The findings, published in JAMA Neurology, show that the relationship between blood biomarker levels and brain amyloid was largely similar across racial groups.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Blood Biomarkers to Detect Alzheimer Disease in Primary and Secondary Care	0	5.63	15-10-2024
2	Novel biomarker beats leading diagnostic blood test at predicting Alzheimer's progression	5	7	01-07-2026
3	Blood test could help identify people at high risk for Alzheimer's disease, study shows	2	7	15-07-2026
4	RNA biomarkers identified that could offer a simple blood test for earlier Alzheimer's diagnosis	6	7	22-06-2026
5	Blood test could help identify people at high risk for Alzheimer's disease, study shows	5	7	15-07-2026
6	FDA approves new blood test for Alzheimer’s disease	0	4.9	24-08-2026
7	Blood proteins shift during Alzheimer's treatment and may help monitor the effects of the medication	0	6.08	24-09-2026
8	Study shows a blood test can help identify healthy people at high risk for Alzheimer's disease	0	7	15-07-2026
9	Study shows a blood test can help identify healthy people at high risk for Alzheimer's disease	0	7	15-07-2026
10	Alzheimer’s Blood Tests Offer New Promise to Diagnose and Predict the Disease	5	7	15-07-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 5.79. Источник: medicalxpress.com.